NLM-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NLM-001, covering 2024-12-30 to 2024-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]